Avivagen Inc. (OTCMKTS:VIVXF) Sees Large Increase in Short Interest

Avivagen Inc. (OTCMKTS:VIVXFGet Rating) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totalling 1,900 shares, a growth of 280.0% from the April 30th total of 500 shares. Based on an average daily trading volume, of 10,200 shares, the days-to-cover ratio is presently 0.2 days.

Shares of OTCMKTS VIVXF opened at $0.16 on Thursday. The firm’s 50-day moving average price is $0.16 and its 200-day moving average price is $0.20. The stock has a market capitalization of $10.23 million, a price-to-earnings ratio of -1.56 and a beta of 0.21. Avivagen has a 12-month low of $0.15 and a 12-month high of $0.38.

About Avivagen (Get Rating)

Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.

Read More

Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.